Sort
82,697 grants matching “vaccine development”
Task V03: Product Development Plans
$1,297,428Thomas Hassell · International Aids Vaccine Initiative · N01 · FY2019 · AI
Chicago Clinical Trials Unit
$1,297,285Robert L. Murphy · Northwestern University At Chicago · UM1 · FY2017 · AI
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,297,094Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2021 · AI
Influenza Viral Pathogenesis
$1,296,634Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Discovery and Translational Core Services
$1,296,283Gerald A Beltz · Harvard Medical School · U19 · FY2016 · AI
A novel Lyme disease vaccine
$1,296,192Erol Fikrig · Yale University · R01 · FY2025 · AI
Development of multi-modal single-cell technology to dissect epitope specificity to HIV
$1,296,133Steven Edward Bosinger · Emory University · U24 · FY2024 · AI
Immunopathogenesis of Fungal Infections
$1,296,078Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Nonhuman Primate Trials
$1,296,052Elizabeth Strobert · Emory University · P01 · FY2011 · AI
Stimulant Pharmacotherapy: Noradrenergic Targets
$1,296,042Thomas Richard Kosten · Baylor College Of Medicine · P50 · FY2011 · DA
NLM's Personal Health Record and Consumer Service R&D
$1,295,971Clement McDonald · National Library Of Medicine · ZIA · FY2009 · LM
SAN FRANCISCO HIV VACCINE CLINICAL TRAILS UNIT
$1,295,930Public Health Foundation Enterprises · U01 · FY2001 · AI
Lung Cancer Program
$1,295,636Giuseppe Giaccone · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Host Immunity Against Bacteria
$1,295,427Sandip Datta · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,295,221Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
CPTR - Mass Spectrometry Unit
$1,295,034Lisa Jenkins · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Institute for Clinical and Translational Research
$1,294,527Daniel Ernest Ford · Johns Hopkins University · KL2 · FY2013 · TR
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,294,431Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2022 · AI
BLOOD GROUP ANTIGENS IN HEALTH AND DISEASE
$1,294,342New York Blood Center · P50 · FY2001 · HL
Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central Africa
$1,294,249Anavaj Sakuntabhai · Institut Pasteur · U01 · FY2023 · AI
Innate inflammatory responses during pulmonary infections
$1,293,685Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
NIMHD-Research Center of Excellence at the University of Maryland
$1,293,634Stephen B. Thomas · Univ Of Maryland, College Park · P60 · FY2011 · MD
Task A43: Establishment of a Chronic Bacterial Lung Infection Model in Ã-ENaC Mice
$1,293,315Joanne Shanklin · Univ Of North Carolina Chapel Hill · N01 · FY2020 · AI
FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION
$1,293,012Prema Robinson · University Of Tx Md Anderson Can Ctr · N01 · FY2023 · CA
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
$1,292,577Mark Larche · Mcmaster University · U19 · FY2014 · AI